Published in Radiother Oncol on January 05, 2006
Clinical outcome of protocol based image (MRI) guided adaptive brachytherapy combined with 3D conformal radiotherapy with or without chemotherapy in patients with locally advanced cervical cancer. Radiother Oncol (2011) 2.85
Radiation dose-volume effects of the urinary bladder. Int J Radiat Oncol Biol Phys (2010) 2.14
Clinical implementation of a new electronic brachytherapy system for skin brachytherapy. J Contemp Brachytherapy (2014) 1.77
Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (IV): Basic principles and parameters for MR imaging within the frame of image based adaptive cervix cancer brachytherapy. Radiother Oncol (2012) 1.54
Prospective clinical trial of bladder filling and three-dimensional dosimetry in high-dose-rate vaginal cuff brachytherapy. Int J Radiat Oncol Biol Phys (2008) 1.47
3-T MR-guided brachytherapy for gynecologic malignancies. Magn Reson Imaging (2012) 1.30
Adaptive image guided brachytherapy for cervical cancer: a combined MRI-/CT-planning technique with MRI only at first fraction. Radiother Oncol (2012) 1.19
Dosimetric impact of point A definition on high-dose-rate brachytherapy for cervical cancer: evaluations on conventional point A and MRI-guided, conformal plans. J Contemp Brachytherapy (2012) 1.19
Dosimetric comparison of brachytherapy sources for high-dose-rate treatment of endometrial cancer: (192)Ir, (60)Co and an electronic brachytherapy source. Br J Radiol (2016) 1.09
Treatment planning study of the 3D dosimetric differences between Co-60 and Ir-192 sources in high dose rate (HDR) brachytherapy for cervix cancer. J Contemp Brachytherapy (2012) 1.08
Correlation of point B and lymph node dose in 3D-planned high-dose-rate cervical cancer brachytherapy. Int J Radiat Oncol Biol Phys (2009) 1.07
Prognostic factors and morbidities after completion surgery in patients undergoing initial chemoradiation therapy for locally advanced cervical cancer. Oncologist (2010) 1.05
MRI assessment of cervical cancer for adaptive radiotherapy. Strahlenther Onkol (2009) 1.04
Feasibility of transrectal ultrasonography for assessment of cervical cancer. Strahlenther Onkol (2012) 1.01
Major clinical research advances in gynecologic cancer in 2012. J Gynecol Oncol (2013) 0.96
Dosimetric impacts of applicator displacements and applicator reconstruction-uncertainties on 3D image-guided brachytherapy for cervical cancer. J Contemp Brachytherapy (2013) 0.95
Comparison of 3D MRI with high sampling efficiency and 2D multiplanar MRI for contouring in cervix cancer brachytherapy. Radiol Oncol (2012) 0.94
A multicentre comparison of the dosimetric impact of inter- and intra-fractional anatomical variations in fractionated cervix cancer brachytherapy. Radiother Oncol (2013) 0.94
Local recurrences in cervical cancer patients in the setting of image-guided brachytherapy: a comparison of spatial dose distribution within a matched-pair analysis. Radiother Oncol (2011) 0.94
A study of high-dose-rate intracavitary brachytherapy boost for curative treatment of uterine cervical cancer. J Contemp Brachytherapy (2015) 0.94
Radiotherapy planning using MRI. Phys Med Biol (2015) 0.93
The role of PET/CT in cervical cancer. Front Oncol (2013) 0.93
Magnetic resonance image guided brachytherapy. Semin Radiat Oncol (2014) 0.92
Use of transrectal ultrasound for high dose rate interstitial brachytherapy for patients of carcinoma of uterine cervix. J Gynecol Oncol (2010) 0.92
A survey of quality control practices for high dose rate (HDR) and pulsed dose rate (PDR) brachytherapy in the United Kingdom. J Contemp Brachytherapy (2012) 0.92
Comparison and consensus guidelines for delineation of clinical target volume for CT- and MR-based brachytherapy in locally advanced cervical cancer. Int J Radiat Oncol Biol Phys (2014) 0.92
Image-guided brachytherapy (IGBT) combined with whole pelvic intensity-modulated radiotherapy (WP-IMRT) for locally advanced cervical cancer: a prospective study from Chiang Mai University Hospital, Thailand. J Contemp Brachytherapy (2013) 0.92
Comparison of Axxent-Xoft, (192)Ir and (60)Co high-dose-rate brachytherapy sources for image-guided brachytherapy treatment planning for cervical cancer. Br J Radiol (2015) 0.92
Comparison of apparent diffusion coefficient maps to T2-weighted images for target delineation in cervix cancer brachytherapy. J Contemp Brachytherapy (2011) 0.90
Uterine perforation - 5-year experience in 3-D image guided gynaecological brachytherapy at Institute of Oncology Ljubljana. Radiol Oncol (2013) 0.90
Brachytherapy for malignancies of the vagina in the 3D era. J Contemp Brachytherapy (2015) 0.90
Adaptive 3D image-guided brachytherapy: a strong argument in the debate on systematic radical hysterectomy for locally advanced cervical cancer. Oncologist (2013) 0.89
International Conference on Advances in Radiation Oncology (ICARO): outcomes of an IAEA meeting. Radiat Oncol (2011) 0.89
Current status and perspectives of brachytherapy for cervical cancer. Int J Clin Oncol (2009) 0.89
Brachytherapy in the treatment of cervical cancer: a review. Int J Womens Health (2014) 0.88
Electronic brachytherapy for superficial and nodular basal cell carcinoma: a report of two prospective pilot trials using different doses. J Contemp Brachytherapy (2016) 0.88
Effect of bladder distension on dosimetry of organs at risk in computer tomography based planning of high-dose-rate intracavitary brachytherapy for cervical cancer. J Contemp Brachytherapy (2013) 0.88
Rapid emission angle selection for rotating-shield brachytherapy. Med Phys (2013) 0.88
High resolution (3 Tesla) MRI-guided conformal brachytherapy for cervical cancer: consequences of different high-risk CTV sizes. J Contemp Brachytherapy (2013) 0.88
MRI-based pre-planning in patients with cervical cancer treated with three-dimensional brachytherapy. Br J Radiol (2011) 0.88
Sigmoid dose using 3D imaging in cervical-cancer brachytherapy. Radiother Oncol (2009) 0.87
Effects of bladder distension on dose distribution of vaginal vault brachytherapy in patients with endometrial cancer. J Contemp Brachytherapy (2014) 0.87
Non isocentric film-based intracavitary brachytherapy planning in cervical cancer: a retrospective dosimetric analysis with CT planning. J Contemp Brachytherapy (2012) 0.87
Outpatient combined intracavitary and interstitial cervical brachytherapy: barriers and solutions to implementation of a successful programme - a single institutional experience. J Contemp Brachytherapy (2015) 0.87
Validation of catheter segmentation for MR-guided gynecologic cancer brachytherapy. Med Image Comput Comput Assist Interv (2013) 0.87
Biological effective dose evaluation and assessment of rectal and bladder complications for cervical cancer treated with radiotherapy and surgery. J Contemp Brachytherapy (2012) 0.86
Can point doses predict volumetric dose to rectum and bladder: a CT-based planning study in high dose rate intracavitary brachytherapy of cervical carcinoma? Br J Radiol (2011) 0.85
IMRT with ¹⁸FDG-PET\CT based simultaneous integrated boost for treatment of nodal positive cervical cancer. Radiat Oncol (2014) 0.85
Image-guided therapy system for interstitial gynecologic brachytherapy in a multimodality operating suite. Springerplus (2013) 0.85
Concomitant cervical and transperineal parametrial high-dose-rate brachytherapy boost for locally advanced cervical cancer. J Contemp Brachytherapy (2016) 0.85
Review of advanced catheter technologies in radiation oncology brachytherapy procedures. Cancer Manag Res (2015) 0.85
Brachytherapy-emulating robotic radiosurgery in patients with cervical carcinoma. Radiat Oncol (2013) 0.84
Predictors of distant metastasis after combined HDR brachytherapy and external beam radiation for prostate cancer. J Contemp Brachytherapy (2013) 0.84
Dose-volume parameters and clinical outcome of CT-guided free-hand high-dose-rate interstitial brachytherapy for cervical cancer. Chin J Cancer (2012) 0.84
A new template for MRI-based intracavitary/interstitial gynecologic brachytherapy: design and clinical implementation. J Contemp Brachytherapy (2015) 0.84
MRI findings at image guided adaptive cervix cancer brachytherapy: radiation oncologist's perspective. J Contemp Brachytherapy (2014) 0.84
Three-dimensional image-based high-dose-rate interstitial brachytherapy for mobile tongue cancer. J Radiat Res (2013) 0.84
Commissioning a CT-compatible LDR tandem and ovoid applicator using Monte Carlo calculation and 3D dosimetry. Med Phys (2012) 0.84
A prospective observational study with dose volume parameters predicting rectosigmoidoscopic findings and late rectosigmoid bleeding in patients with uterine cervical cancer treated by definitive radiotherapy. Radiat Oncol (2013) 0.84
Image-guided high-dose-rate brachytherapy in inoperable endometrial cancer. Br J Radiol (2014) 0.84
MRI-assisted cervix cancer brachytherapy pre-planning, based on application in paracervical anaesthesia: final report. Radiol Oncol (2014) 0.84
Potential role of TRAns Cervical Endosonography (TRACE) in brachytherapy of cervical cancer: proof of concept. J Contemp Brachytherapy (2016) 0.83
Magnetic resonance imaging-guided brachytherapy for cervical cancer: initiating a program. J Contemp Brachytherapy (2015) 0.83
Image guided adaptive brachytherapy for cervical cancer: dose contribution to involved pelvic nodes in two cancer centers. J Contemp Brachytherapy (2014) 0.83
Dosimetric study for cervix carcinoma treatment using intensity modulated radiation therapy (IMRT) compensation based on 3D intracavitary brachytherapy technique. J Contemp Brachytherapy (2016) 0.82
Biological equivalence between LDR and PDR in cervical cancer: multifactor analysis using the linear-quadratic model. J Contemp Brachytherapy (2011) 0.82
Radiation sigmoiditis mimicking sigmoid colon cancer after radiation therapy for cervical cancer: the implications of three-dimensional image-based brachytherapy planning. J Gynecol Oncol (2012) 0.82
The effect of central shielding in the dose reporting for cervical cancer in EQD2 era. J Contemp Brachytherapy (2013) 0.82
Why are we still in the 1950s regarding management of cancer of uterine cervix ? J Med Phys (2012) 0.82
In vivo dosimetry: trends and prospects for brachytherapy. Br J Radiol (2014) 0.82
Dynamic rotating-shield brachytherapy. Med Phys (2013) 0.82
Dosimetry analyses comparing high-dose-rate brachytherapy, administered as monotherapy for localized prostate cancer, with stereotactic body radiation therapy simulated using CyberKnife. J Radiat Res (2014) 0.82
A comparison of dose distribution from Manchester-style and Fletcher-style intracavitary brachytherapy applicator systems in cervical cancer. J Contemp Brachytherapy (2012) 0.82
Improving the efficiency of image guided brachytherapy in cervical cancer. J Contemp Brachytherapy (2016) 0.82
Redesign of process map to increase efficiency: Reducing procedure time in cervical cancer brachytherapy. Brachytherapy (2015) 0.82
Different effects of bladder distention on point A-based and 3D-conformal intracavitary brachytherapy planning for cervical cancer. J Radiat Res (2012) 0.82
Efficacy and safety of nedaplatin-based concurrent chemoradiotherapy for FIGO Stage IB2-IVA cervical cancer and its clinical prognostic factors. J Radiat Res (2014) 0.81
A practical MRI-based reconstruction method for a new endocavitary and interstitial gynaecological template. J Contemp Brachytherapy (2015) 0.81
Comparison of dose-volume analysis between standard Manchester plan and magnetic resonance image-based plan of intracavitary brachytherapy for uterine cervical cancer. J Radiat Res (2012) 0.81
Inverse planning for combination of intracavitary and interstitial brachytherapy for locally advanced cervical cancer. J Radiat Res (2013) 0.81
Brachytherapy in cancer cervix: Time to move ahead from point A? World J Clin Oncol (2014) 0.81
Assessing cumulative dose distributions in combined radiotherapy for cervical cancer using deformable image registration with pre-imaging preparations. Radiat Oncol (2014) 0.80
Dosimetric consequences of interobserver variability in delineating the organs at risk in gynecologic interstitial brachytherapy. Int J Radiat Oncol Biol Phys (2014) 0.80
Interfractional change of high-risk CTV D90 during image-guided brachytherapy for uterine cervical cancer. J Radiat Res (2013) 0.80
University Cooperation Platform (UCP) between Christian-Albrechts-University Kiel (Germany) and Chiang Mai University (Thailand): implementation of image-guided gynecological brachytherapy. J Contemp Brachytherapy (2015) 0.80
CT based three dimensional dose-volume evaluations for high-dose rate intracavitary brachytherapy for cervical cancer. BMC Cancer (2014) 0.80
Dose escalation in brachytherapy for cervical cancer: impact on (or increased need for) MRI-guided plan optimisation. Br J Radiol (2012) 0.80
Dose error from deviation of dwell time and source position for high dose-rate 192Ir in remote afterloading system. J Radiat Res (2014) 0.80
The future of Radiation Oncology: Considerations of Young Medical Doctor. Rep Pract Oncol Radiother (2012) 0.79
The role of interstitial brachytherapy in the management of primary radiation therapy for uterine cervical cancer. J Contemp Brachytherapy (2016) 0.79
Recent developments and best practice in brachytherapy treatment planning. Br J Radiol (2014) 0.79
Optimum organ volume ranges for organs at risk dose in cervical cancer intracavitary brachytherapy. J Contemp Brachytherapy (2016) 0.79
Definitive radiotherapy for uterine cervix cancer: long term results for patients treated in the period from 1998 till 2002 at the Institute of Oncology Ljubljana. Radiol Oncol (2013) 0.79
Mapping of dose distribution from IMRT onto MRI-guided high dose rate brachytherapy using deformable image registration for cervical cancer treatments: preliminary study with commercially available software. J Contemp Brachytherapy (2014) 0.79
Electromagnetic tracking for treatment verification in interstitial brachytherapy. J Contemp Brachytherapy (2016) 0.78
A questionnaire-based survey on 3D image-guided brachytherapy for cervical cancer in Japan: advances and obstacles. J Radiat Res (2015) 0.78
Vaginal tolerance of CT based image-guided high-dose rate interstitial brachytherapy for gynecological malignancies. Radiat Oncol (2014) 0.78
The dosimetric impact of vaginal balloon-packing on intracavitary high-dose-rate brachytherapy for gynecological cancer. J Contemp Brachytherapy (2013) 0.78
Endometrial cancer. Lancet (2005) 5.50
Internal Mammary and Medial Supraclavicular Irradiation in Breast Cancer. N Engl J Med (2015) 5.08
Effect of population-based screening on breast cancer mortality. Lancet (2011) 5.06
Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV. Radiother Oncol (2005) 4.68
Computed tomography versus magnetic resonance imaging-based contouring in cervical cancer brachytherapy: results of a prospective trial and preliminary guidelines for standardized contours. Int J Radiat Oncol Biol Phys (2007) 3.38
Proposed guidelines for image-based intracavitary brachytherapy for cervical carcinoma: report from Image-Guided Brachytherapy Working Group. Int J Radiat Oncol Biol Phys (2004) 2.98
Clinical outcome of protocol based image (MRI) guided adaptive brachytherapy combined with 3D conformal radiotherapy with or without chemotherapy in patients with locally advanced cervical cancer. Radiother Oncol (2011) 2.85
Dose effect relationship for late side effects of the rectum and urinary bladder in magnetic resonance image-guided adaptive cervix cancer brachytherapy. Int J Radiat Oncol Biol Phys (2011) 2.48
Histologic results of para-aortic lymphadenectomy in patients treated for stage IB2/II cervical cancer with negative [18F]fluorodeoxyglucose positron emission tomography scans in the para-aortic area. J Clin Oncol (2008) 2.23
Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer. Radiother Oncol (2007) 2.18
Gynaecological cancers in pregnancy. Lancet (2012) 2.11
The American Brachytherapy Society recommendations for low-dose-rate brachytherapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys (2002) 2.09
Dose-volume histogram parameters and late side effects in magnetic resonance image-guided adaptive cervical cancer brachytherapy. Int J Radiat Oncol Biol Phys (2010) 2.05
Breast conserving therapy versus mastectomy for stage I-II breast cancer: 20 year follow-up of the EORTC 10801 phase 3 randomised trial. Lancet Oncol (2012) 1.97
Randomized comparison between intracoronary beta-radiation brachytherapy and implantation of paclitaxel-eluting stents for the treatment of diffuse in-stent restenosis. Radiother Oncol (2006) 1.94
A systems genetics approach identifies genes and pathways for type 2 diabetes in human islets. Cell Metab (2012) 1.93
Impact of the boost dose of 10 Gy versus 26 Gy in patients with early stage breast cancer after a microscopically incomplete lumpectomy: 10-year results of the randomised EORTC boost trial. Radiother Oncol (2008) 1.88
Dose and volume parameters for MRI-based treatment planning in intracavitary brachytherapy for cervical cancer. Int J Radiat Oncol Biol Phys (2005) 1.86
Outcomes after combined therapy including surgical resection in patients with epithelial ovarian cancer recurrence(s) exclusively in lymph nodes. Ann Surg Oncol (2004) 1.75
The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer: design, application, treatment planning, and dosimetric results. Int J Radiat Oncol Biol Phys (2006) 1.75
Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group: considerations and pitfalls in commissioning and applicator reconstruction in 3D image-based treatment planning of cervix cancer brachytherapy. Radiother Oncol (2010) 1.75
Recommendations for image-based intracavitary brachytherapy of cervix cancer: the GYN GEC ESTRO Working Group point of view: in regard to Nag et al. (Int J Radiat Oncol Biol Phys 2004;60:1160-1172). Int J Radiat Oncol Biol Phys (2005) 1.75
Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy for the definitive treatment of cervix cancer. Int J Radiat Oncol Biol Phys (2010) 1.73
Dose-effect relationship for local control of cervical cancer by magnetic resonance image-guided brachytherapy. Radiother Oncol (2009) 1.70
Dose-volume histogram parameters and local tumor control in magnetic resonance image-guided cervical cancer brachytherapy. Int J Radiat Oncol Biol Phys (2009) 1.68
Common breast cancer susceptibility loci are associated with triple-negative breast cancer. Cancer Res (2011) 1.65
Effect of age and radiation dose on local control after breast conserving treatment: EORTC trial 22881-10882. Radiother Oncol (2006) 1.64
American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part II: high-dose-rate brachytherapy. Brachytherapy (2012) 1.57
Impact of an exercise intervention on DNA methylation in skeletal muscle from first-degree relatives of patients with type 2 diabetes. Diabetes (2012) 1.54
The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer: clinical feasibility and preliminary results. Int J Radiat Oncol Biol Phys (2006) 1.54
Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (IV): Basic principles and parameters for MR imaging within the frame of image based adaptive cervix cancer brachytherapy. Radiother Oncol (2012) 1.54
Prognostic factors of a large retrospective series of mucinous borderline tumors of the ovary (excluding peritoneal pseudomyxoma). Ann Surg Oncol (2010) 1.53
Hepatic tumors treated with percutaneous radio-frequency ablation: CT and MR imaging follow-up. Radiology (2002) 1.44
Is this the swan song of endovascular brachytherapy? Radiother Oncol (2006) 1.41
Brachytherapy in children with rhabdomyosarcomas of the nasolabial fold. Pediatr Blood Cancer (2014) 1.40
In regard to Hattangadi et al (Int J Radiat Oncol Biol Phys. Epub Nov 17, 2011): Accelerated partial breast irradiation with low-dose-rate interstitial implant brachytherapy after wide local excision: 12-year outcomes from a prospective trial. Int J Radiat Oncol Biol Phys (2012) 1.39
[White paper on radiation oncology in France. Twelve proposals to improve a major cancer treatment. Société française de radiothérapie oncologique]. Cancer Radiother (2013) 1.39
Vaginal dose point reporting in cervical cancer patients treated with combined 2D/3D external beam radiotherapy and 2D/3D brachytherapy. Radiother Oncol (2013) 1.39
First case of a centropelvic recurrence after radical trachelectomy: literature review and implications for the preoperative selection of patients. Gynecol Oncol (2004) 1.37
American Brachytherapy Society survey regarding practice patterns of postoperative irradiation for endometrial cancer: current status of vaginal brachytherapy. Int J Radiat Oncol Biol Phys (2005) 1.37
Neoadjuvant FOLFIRINOX for borderline resectable pancreas cancer: a new treatment paradigm? Oncologist (2014) 1.34
Cisplatin in combination with either gemcitabine or irinotecan in carcinomas of unknown primary site: results of a randomized phase II study--trial for the French Study Group on Carcinomas of Unknown Primary (GEFCAPI 01). J Clin Oncol (2003) 1.30
American Brachytherapy Society consensus guidelines for adjuvant vaginal cuff brachytherapy after hysterectomy. Brachytherapy (2012) 1.28
Debilitating musculoskeletal pain and stiffness with letrozole and exemestane: associated tenosynovial changes on magnetic resonance imaging. Breast Cancer Res Treat (2006) 1.26
Patterns of radiotherapy practice for patients with carcinoma of the uterine cervix: a patterns of care study. Int J Radiat Oncol Biol Phys (2004) 1.25
Potential of dose optimisation in MRI-based PDR brachytherapy of cervix carcinoma. Radiother Oncol (2007) 1.23
Systematic evaluation of MRI findings in different stages of treatment of cervical cancer: potential of MRI on delineation of target, pathoanatomic structures, and organs at risk. Int J Radiat Oncol Biol Phys (2006) 1.21
Phase II study of cetuximab as first-line single-drug therapy in patients with unresectable squamous cell carcinoma of the skin. J Clin Oncol (2011) 1.20
Extended-field irradiation and intracavitary brachytherapy combined with cisplatin chemotherapy for cervical cancer with positive para-aortic or high common iliac lymph nodes: results of ARM 1 of RTOG 0116. Int J Radiat Oncol Biol Phys (2007) 1.20
Adaptive image guided brachytherapy for cervical cancer: a combined MRI-/CT-planning technique with MRI only at first fraction. Radiother Oncol (2012) 1.19
Treatment planning for MRI assisted brachytherapy of gynecologic malignancies based on total dose constraints. Int J Radiat Oncol Biol Phys (2007) 1.19
Correlation of dose-volume parameters, endoscopic and clinical rectal side effects in cervix cancer patients treated with definitive radiotherapy including MRI-based brachytherapy. Radiother Oncol (2009) 1.19
Inter-observer comparison of target delineation for MRI-assisted cervical cancer brachytherapy: application of the GYN GEC-ESTRO recommendations. Radiother Oncol (2008) 1.18
MRI-based low dose-rate brachytherapy experience in locally advanced cervical cancer patients initially treated by concomitant chemoradiotherapy. Radiother Oncol (2010) 1.18
Does estrogen receptor negative/progesterone receptor positive breast carcinoma exist? J Clin Oncol (2008) 1.17
Impact of 3D image-based PDR brachytherapy on outcome of patients treated for cervix carcinoma in France: results of the French STIC prospective study. Radiother Oncol (2012) 1.17
Inter- and intraobserver variation in HR-CTV contouring: intercomparison of transverse and paratransverse image orientation in 3D-MRI assisted cervix cancer brachytherapy. Radiother Oncol (2008) 1.17
Physics contributions and clinical outcome with 3D-MRI-based pulsed-dose-rate intracavitary brachytherapy in cervical cancer patients. Int J Radiat Oncol Biol Phys (2008) 1.17